Actively Recruiting
Validation of the REMINDER Dementia Risk Reduction Program
Led by University of Coimbra · Updated on 2024-05-08
400
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
Sponsors
U
University of Coimbra
Lead Sponsor
F
Fundação para a Ciência e a Tecnologia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Until now, neuropsychological interventions aimed to optimize cognitive function and to have functional impact in individuals at risk of AD (MCI patients) were scarce in validity studies. While some RCTs have been developed in cognitive training interventions, comparative studies of merged interventions (cognitive, social and behavioral stimulation) with adequate control groups are absent, diminishing the professionals' trust on the adoption of these interventions for supporting patients. As such, the present proposal will develop a validation trial testing a multicomponent neuropsychological intervention (REMINDER), based on personal development, cognitive compensatory aids, meaningful goals setting, and behavior change techniques. The investigators will analyze its short/long-term gains and AD conversion rates. By aiming to provide a good validation study for REMINDER, the investigators will examine neurobiological, neurocognitive and functional outcomes of this intervention in comparison with an active control group (psychoeducation) in order to foster an effective outcome assessment of an intervention for individuals at risk of AD.
CONDITIONS
Official Title
Validation of the REMINDER Dementia Risk Reduction Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 or older
- CAIDE dementia risk score greater than 8
- No significant cognitive impairment according to Addenbrooke's Cognitive Examination-REVISED
- No physical disabilities preventing study participation
- Willingness to complete all study-related activities for 12 weeks
You will not qualify if you...
- Diagnosis of mild cognitive impairment or dementia
- History of neurological events affecting cognition
- Presence of severe psychiatric disorders (mild depressive or anxiety symptoms allowed)
- Inability to travel to the session site (online option available for REMINDER group)
- Illiteracy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Psychology and Educational Sciences
Coimbra, Portugal, 3002-115
Actively Recruiting
Research Team
A
Ana Rita Silva, PhD
CONTACT
U
University of Coimbra
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here